| |
| |
|
| Insider
Information: |
Dentzer James E |
| Relationship: |
President & CEO, Direc... |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
96,952 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$364,969 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
96,952 |
|
|
| Total
Value |
$364,969 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Financial Officer |
2009-10-01 |
32,075 |
|
0 |
Premium* |
|
|
Curis Inc |
CRIS |
President & CEO, Direc... |
2022-01-31 |
64,877 |
2018-01-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRIS |
Curis Inc |
President & CEO |
• • – |
2021-01-25 |
4 |
AS |
$10.96 |
$25,022 |
D/D |
(2,283) |
70,362 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-08-01 |
4 |
D |
$11.39 |
$2,506 |
D/D |
(220) |
32,515 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2009-07-01 |
4 |
D |
$11.45 |
$2,519 |
D/D |
(220) |
32,735 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-04-01 |
4 |
D |
$11.49 |
$2,528 |
D/D |
(220) |
36,035 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-09-02 |
4 |
D |
$13.86 |
$3,049 |
D/D |
(220) |
34,935 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-10-01 |
4 |
D |
$15.10 |
$3,322 |
D/D |
(220) |
34,715 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-12-03 |
4 |
D |
$15.30 |
$3,366 |
D/D |
(220) |
36,915 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-08-01 |
4 |
D |
$15.61 |
$3,434 |
D/D |
(220) |
35,155 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-11-01 |
4 |
D |
$16.17 |
$3,557 |
D/D |
(220) |
37,135 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-10-02 |
4/A |
D |
$17.10 |
$45,230 |
D/D |
(2,645) |
37,355 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Financial Officer. |
• – – |
2007-10-02 |
4 |
D |
$17.35 |
$43,375 |
D/D |
(2,500) |
37,500 |
0 |
- |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
